VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,943 | -42.1% | 11,098 | -11.7% | 0.00% | – |
| Q2 2023 | $82,790 | +1.4% | 12,563 | +4.5% | 0.00% | – |
| Q1 2023 | $81,609 | -17.8% | 12,019 | -10.5% | 0.00% | – |
| Q4 2022 | $99,262 | -18.6% | 13,432 | +8.2% | 0.00% | – |
| Q3 2022 | $122,000 | -9.0% | 12,418 | +1.3% | 0.00% | – |
| Q2 2022 | $134,000 | -34.0% | 12,255 | -31.9% | 0.00% | – |
| Q1 2022 | $203,000 | -39.8% | 18,001 | -16.5% | 0.00% | -100.0% |
| Q4 2021 | $337,000 | -3.4% | 21,558 | +6.0% | 0.00% | 0.0% |
| Q3 2021 | $349,000 | -36.9% | 20,344 | -20.9% | 0.00% | -50.0% |
| Q2 2021 | $553,000 | +56.2% | 25,709 | +9.0% | 0.00% | +100.0% |
| Q1 2021 | $354,000 | +26.0% | 23,576 | +10.2% | 0.00% | 0.0% |
| Q4 2020 | $281,000 | +77.8% | 21,393 | +30.6% | 0.00% | 0.0% |
| Q3 2020 | $158,000 | -18.6% | 16,381 | -3.2% | 0.00% | 0.0% |
| Q2 2020 | $194,000 | +65.8% | 16,928 | +50.4% | 0.00% | 0.0% |
| Q1 2020 | $117,000 | -64.4% | 11,257 | -43.9% | 0.00% | -50.0% |
| Q4 2019 | $329,000 | +14.2% | 20,060 | -7.5% | 0.00% | 0.0% |
| Q3 2019 | $288,000 | -8.9% | 21,678 | -3.3% | 0.00% | 0.0% |
| Q2 2019 | $316,000 | -31.3% | 22,420 | -10.3% | 0.00% | -33.3% |
| Q1 2019 | $460,000 | -28.6% | 24,981 | +1.3% | 0.00% | -40.0% |
| Q4 2018 | $644,000 | +1.6% | 24,660 | -10.8% | 0.01% | +25.0% |
| Q3 2018 | $634,000 | +16.1% | 27,642 | -3.6% | 0.00% | 0.0% |
| Q2 2018 | $546,000 | +21.6% | 28,661 | +7.6% | 0.00% | +33.3% |
| Q1 2018 | $449,000 | -3.9% | 26,638 | -13.4% | 0.00% | 0.0% |
| Q4 2017 | $467,000 | -7.7% | 30,744 | +8.7% | 0.00% | -40.0% |
| Q3 2017 | $506,000 | +16.1% | 28,291 | +5.7% | 0.01% | +25.0% |
| Q2 2017 | $436,000 | +11.8% | 26,760 | -4.0% | 0.00% | 0.0% |
| Q1 2017 | $390,000 | -30.0% | 27,887 | -20.1% | 0.00% | -33.3% |
| Q4 2016 | $557,000 | +8.4% | 34,918 | +13.0% | 0.01% | -14.3% |
| Q3 2016 | $514,000 | +25.4% | 30,912 | -15.6% | 0.01% | +40.0% |
| Q2 2016 | $410,000 | +32.7% | 36,607 | -1.1% | 0.01% | +25.0% |
| Q1 2016 | $309,000 | -18.0% | 37,018 | -8.6% | 0.00% | -20.0% |
| Q4 2015 | $377,000 | -7.8% | 40,519 | +11.8% | 0.01% | -16.7% |
| Q3 2015 | $409,000 | -16.7% | 36,240 | -6.3% | 0.01% | -14.3% |
| Q2 2015 | $491,000 | +28.5% | 38,672 | -5.9% | 0.01% | +75.0% |
| Q1 2015 | $382,000 | -22.2% | 41,085 | +19.9% | 0.00% | -33.3% |
| Q4 2014 | $491,000 | +53.0% | 34,277 | +10.9% | 0.01% | +50.0% |
| Q3 2014 | $321,000 | -46.5% | 30,913 | -16.6% | 0.00% | -50.0% |
| Q2 2014 | $600,000 | -37.6% | 37,073 | -37.4% | 0.01% | -33.3% |
| Q1 2014 | $962,000 | +355.9% | 59,224 | +247.6% | 0.01% | +300.0% |
| Q4 2013 | $211,000 | -41.1% | 17,037 | -47.7% | 0.00% | -62.5% |
| Q3 2013 | $358,000 | +86.5% | 32,596 | +37.1% | 0.01% | +100.0% |
| Q2 2013 | $192,000 | – | 23,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |